SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?


To: Jimmy Nicholson who wrote (173)1/14/1999 4:07:00 PM
From: Cindy Powell  Read Replies (1) | Respond to of 196
 
News!

Medical Discoveries, Inc. Enters $3 Billion Scar Treatment Market
LAYTON, Utah, Jan. 14 /PRNewswire/ -- Medical Discoveries, Inc. (OTC Bulletin Board: MLSC - news) announced today that it's newly formed Consumer Products division, MDI HealthCare Systems, Inc., has launched the first in a series of scar management/skin care products, which are derived from its patented and proprietary electrolysis and other technologies. The company's flagship product, InvisiScar™ the invisible scar therapy™ treatment, is the first in a series of scar management/skin care products to be introduced by MDI HealthCare Systems, Inc.

''The launching of InvisiScar™ is part of a corporate strategy to maximize the innovative, proven technologies and intellectual property of our parent company, Medical Discoveries, Inc., by developing products targeted at profitable and growing consumer markets where we can make a significant contribution. The scar management/wound care market in the United States is estimated to be $3.5 billion, and growing, with 63 million new scars formed every year'', stated Lee F. Kulas, President and CEO, ''and MDI HealthCare Systems, Inc. intends to be a significant player in this exciting market.''

InvisiScar™ is a discreet, convenient, effective two-step therapy that combines two proven therapeutic agents to help soften, flatten and diminish unsightly scar tissue. Step One: Aqua Cleanse™ pretreatment pads are used to cleanse, hydrate and disinfect the skin and soften scar tissue. Step Two: InvisiScar™ offers the consumer all the benefits of ''gel sheeting'' without the difficulties associated with its application. InvisiScar™ is an invisible, odor-free, moisturizing topical gel that works discretely around-the-clock to soften, flatten, and reduce scar tissue to a more normal color and texture.

''The trend today is for the development of scar management and treatment alternatives which are easy to use, affordable, effective and safe,'' stated MDI HealthCare Systems, Inc., VP Research & Development, Jack Kushner. ''Based upon the science, research, testing and proprietary technologies used, InvisiScar™ is an effective and affordable treatment for skin trauma including cuts, burns, scars and cystic acne.''

The company has already signed major distribution agreements both in the United States and selected overseas markets. According to Neal G. Ofiesh, VP Sales, ''We are using a combination of corporate distribution agreements, independent distributors selling to the medical community, and direct consumer sales via nationwide advertising in selected women's magazines.''

Director of Operations, Troy Fullmer advised, ''We have been ramping up production during the last few weeks in accordance with distributor requirements, and are ahead of schedule for our national launch this month. Now our focus is transferring two products from development into manufacturing for launching in March and April.''

For further information about InvisiScar™ and the other scar management/skin care products provided by MDI HealthCare Systems, Inc., please direct all inquiries as follows: Distribution Availability: Neal G. Ofiesh, Vice President of Sales: (724-334-0500); Ordering Information: (1-877-343-6373) for all other Questions: Troy Fullmer, Director of Operations, (801-771-0523).

SOURCE: Medical Discoveries, Inc.

--------------------------------------------------------------------------------